ClinicalTrials.gov
public full text
Public Domain
Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)
Nitroprusside is used commonly in the Intensive Care Unit for long periods of time in order to reduce blood pressure. It is not known if the body compensates over time to the blood pressure lowering, and if when the nitroprusside is stopped the blood pressure goes up at a faster rate and is higher than it was at the start of the treatment. This study will answer these questions.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects#1085732
- A Study of the Effect of LY2189265 on Two Blood Pressure Drugs#272470
- VITROS Immunodiagnostic Products NT-proBNP II#844586
- A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)#1114608
- MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension#980611
Record · ID 1125715
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive